Clinical Trials Browser

OTHER × vorolanib × Thoracic × Clear all

NCT04373369 2025-11-03

Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Phase 2 Terminated

11 enrolled 10 charts

Small Cell Lung Carcinoma